Avirmax Biopharma Inc. to Exhibit Development of Next Generation Gene Therapies for Ocular Diseases at the AAO 2024 Annual Meeting in Chicago
Avirmax Biopharma Inc. (ABI)team will attend AAO 2024, the American Academy of Ophthalmology’s annual meeting in Chicago, October 17-21, 2024. Avirmax will exhibit at booth #5357 to showcase the latest progress of the ABI gene therapy ocular programs. https://mma.prnewswire.com/media/1915870/Avirmax__Logo.jpg Avirmax Biopharma Is Unlocking Potential of Genetic Medicine, Preserving Vision for Millions of Patients With a […]